Eckardt J - Search Results

1

Development of docetaxel in advanced non-small-cell lung cancer.

Belani CP, Eckardt J. Belani CP, et al. Among authors: eckardt j. Lung Cancer. 2004 Dec;46 Suppl 2:S3-11. doi: 10.1016/s0169-5002(04)80036-9. Lung Cancer. 2004. PMID: 15698529 Review.

2

Single-agent chemotherapy for non-small cell lung cancer.

Eckardt J. Eckardt J. Lung Cancer. 2003 Aug;41 Suppl 4:S17-22. doi: 10.1016/s0169-5002(03)90521-6. Lung Cancer. 2003. PMID: 14565510 Review.

3

Irinotecan plus cisplatin in patients with advanced non-small-cell lung cancer.

Devore R 3rd, Johnson D, Crawford J, Dimery I, Eckardt J, Eckhardt SG. Devore R 3rd, et al. Among authors: eckardt j. Oncology (Williston Park). 1998 Aug;12(8 Suppl 6):79-83. Oncology (Williston Park). 1998. PMID: 9726097 Review.

4

Options for first- and second-line therapy in small cell lung cancer--a workshop discussion.

Thatcher N, Eckardt J, Green M. Thatcher N, et al. Among authors: eckardt j. Lung Cancer. 2003 Aug;41 Suppl 4:S37-41. doi: 10.1016/s0169-5002(03)90525-3. Lung Cancer. 2003. PMID: 14565514

5

Challenging the platinum combinations in the chemotherapy of NSCLC.

Douillard JY, Eckardt J, Scagliotti GV. Douillard JY, et al. Among authors: eckardt j. Lung Cancer. 2002 Dec;38 Suppl 4:21-8. doi: 10.1016/s0169-5002(02)00168-x. Lung Cancer. 2002. PMID: 12480191 Review.

6

Single-agent gemcitabine and gemcitabine/irinotecan combination (irimogem) in non-small cell lung cancer.

Rocha Lima CM, Eckardt JR, Leong SS, Sherman CA, Perkel JA, Putman T, Safa AR, Bahadori HR, Green MR. Rocha Lima CM, et al. Among authors: eckardt jr. Semin Oncol. 1999 Oct;26(5 Suppl 16):43-50; discussion 71-2. Semin Oncol. 1999. PMID: 10585008 Review.

7

Safety and resource utilization by non-small cell lung cancer histology: results from the randomized phase III study of pemetrexed plus cisplatin versus gemcitabine plus cisplatin in chemonaïve patients with advanced non-small cell lung cancer.

Novello S, Pimentel FL, Douillard JY, O'Brien M, von Pawel J, Eckardt J, Liepa AM, Simms L, Visseren-Grul C, Paz-Ares L. Novello S, et al. Among authors: eckardt j. J Thorac Oncol. 2010 Oct;5(10):1602-8. doi: 10.1097/JTO.0b013e3181eaf30f. J Thorac Oncol. 2010. PMID: 20808252 Free article. Clinical Trial.

8

Antitumor activity of docetaxel.

Eckardt JR. Eckardt JR. Am J Health Syst Pharm. 1997 Dec 15;54(24 Suppl 2):S2-6. doi: 10.1093/ajhp/54.suppl_2.S2. Am J Health Syst Pharm. 1997. PMID: 9435925 Review.

9

Challenging the platinum combinations: docetaxel (Taxotere) combined with gemcitabine or vinorelbine in non-small cell lung cancer.

Georgoulias V, Scagliotti G, Miller V, Eckardt J, Douillard JY, Manegold C. Georgoulias V, et al. Among authors: eckardt j. Semin Oncol. 2001 Feb;28(1 Suppl 2):15-21. doi: 10.1016/s0093-7754(01)90299-4. Semin Oncol. 2001. PMID: 11284620 Review.

10

Feasibility of oral topotecan plus intravenous paclitaxel in advanced non-small-cell lung cancer.

Eckardt JR. Eckardt JR. Oncology. 2001;61 Suppl 1:30-4. doi: 10.1159/000055389. Oncology. 2001. PMID: 11598412 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

338 results

Search Page

Filters